Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

NCT01279590 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Myalgia
Hypercholesterolemia
Hyperlipidemia

Interventions

DRUG: PPD10558
DRUG: Atorvastatin
DRUG: Placebo

Sponsor

Furiex Pharmaceuticals, Inc